Published in J Am Coll Cardiol on June 19, 2002
Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med (2012) 1.54
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound (2005) 1.34
One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care (2011) 0.93
Race/ethnic disparities in left ventricular diastolic function in a triethnic community cohort. Am Heart J (2010) 0.87
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. J Hum Hypertens (2013) 0.87
Relationship between Tei index of myocardial performance and left ventricular geometry in Nigerians with systemic hypertension. Cardiovasc J Afr (2011) 0.86
Subclinical Myocardial Dysfunction in Metabolic Syndrome Patients without Hypertension. J Cardiovasc Ultrasound (2011) 0.83
Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res (2014) 0.83
Left ventricular mass and diastolic function in obese children and adolescents. Pediatr Nephrol (2014) 0.83
Myocardial tissue phase mapping reveals impaired myocardial tissue velocities in obesity. Int J Cardiovasc Imaging (2014) 0.81
Correlation between the morning hypertension on ambulatory blood pressure monitoring and the left ventricular mass in children. Korean J Pediatr (2014) 0.81
Imaging in hypertensive heart disease. Expert Rev Cardiovasc Ther (2011) 0.81
Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials. BMC Med (2015) 0.80
Principles of transthoracic echocardiographic evaluation. Nat Rev Cardiol (2015) 0.80
Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt. Br J Pharmacol (2011) 0.80
Alterations in diastolic function in masked hypertension: findings from the masked hypertension study. Am J Hypertens (2013) 0.80
Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond) (2015) 0.79
Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. Heart (2004) 0.79
Association of E/E' and NT-proBNP with renal function in patients with essential hypertension. PLoS One (2013) 0.78
Visit-to-visit blood pressure variability is a marker of cardiac diastolic function and carotid atherosclerosis. BMC Cardiovasc Disord (2014) 0.78
Heart failure with preserved ejection fraction. J Geriatr Cardiol (2013) 0.78
Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial. Drug Des Devel Ther (2013) 0.78
Assessment of left ventricular diastolic function in children after successful repair of aortic coarctation. Clin Res Cardiol (2010) 0.77
Preoperative cardiac variables of diastolic dysfunction and clinical outcomes in lung transplant recipients. J Transplant (2013) 0.76
Left Ventricular Hypertrophy Phenotype in Childhood-Onset Essential Hypertension. J Clin Hypertens (Greenwich) (2015) 0.76
Cardiovascular changes during chronic hypertensive states. Pediatr Nephrol (2013) 0.75
Albuminuria is associated with left ventricular hypertrophy in patients with early diabetic kidney disease. Int J Endocrinol (2014) 0.75
The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects. Cardiovasc J Afr (2015) 0.75
Relation of fragmented QRS to tissue Doppler-derived parametersin patients with familial Mediterranean fever. Wien Klin Wochenschr (2015) 0.75
Aging and transmitral flow pattern in patients with systemic hypertension. J Med Ultrason (2001) (2006) 0.75
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (2009) 6.25
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension (2004) 4.38
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens (2011) 3.50
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) (2006) 3.03
Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension (2007) 2.93
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension (2005) 2.54
Cardiac remodeling in obesity. Circ Cardiovasc Imaging (2013) 2.24
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study. J Clin Hypertens (Greenwich) (2011) 2.04
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol (2006) 2.00
Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension. J Hypertens (2011) 1.97
Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol (2008) 1.81
Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart (2010) 1.80
Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation (2007) 1.78
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77
Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens (2004) 1.65
Improved cardiovascular diagnostic accuracy by pocket size imaging device in non-cardiologic outpatients: the NaUSiCa (Naples Ultrasound Stethoscope in Cardiology) study. Cardiovasc Ultrasound (2010) 1.64
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Impaired inotropic response in type 2 diabetes mellitus: a strain rate imaging study. Am J Hypertens (2007) 1.57
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol (2005) 1.57
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56
Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension. J Hypertens (2004) 1.56
Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. Am J Hypertens (2004) 1.54
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities. J Hypertens (2007) 1.52
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens (2009) 1.48
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol (2004) 1.48
Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J (2013) 1.47
Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol (2004) 1.47
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens (2008) 1.46
Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med (2006) 1.44
Are observational studies more informative than randomized controlled trials in hypertension? Pro side of the argument. Hypertension (2013) 1.44
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens (2008) 1.44
Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. Catheter Cardiovasc Interv (2014) 1.43
Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. J Hypertens (2011) 1.43
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension. Am J Cardiol (2004) 1.42
Atrial fibrillation in hypertension: predictors and outcome. Hypertension (2003) 1.40
Blood pressure lowering in the oldest old. J Hypertens (2010) 1.40
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Reducing blood pressure in people of different ages. BMJ (2008) 1.39
Multivariable analysis in cerebrovascular research: practical notes for the clinician. Cerebrovasc Dis (2013) 1.38
Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? J Hypertens (2004) 1.38
Method errors or unexplained biological information? Hypertension (2010) 1.38
Relations of pulse pressure and other components of blood pressure to preclinical echocardiographic abnormalities. J Hypertens (2002) 1.38
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation (2004) 1.36
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol (2006) 1.36
Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol (2005) 1.36
Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol (2012) 1.29
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol (2012) 1.28
Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension (2009) 1.26
Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum (2005) 1.25
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr (2008) 1.23
Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens (2005) 1.23
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol (2012) 1.19
Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 1.18
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J (2009) 1.17
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens (2003) 1.16
Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr (2007) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension (2006) 1.13
Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens (2010) 1.12
Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension (2002) 1.12
The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy. J Electrocardiol (2010) 1.12
Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens (2007) 1.10
Ambulatory blood pressure for cardiovascular risk stratification. Circulation (2007) 1.10
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension (2008) 1.09
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J (2003) 1.09
Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens (2003) 1.08